The melanocortin‐4 receptor pathway and the emergence of precision medicine in obesity management

Documenti analoghi

• The role of incretin receptor agonists in the treatment of obesity
  di: Thomas Forst, et al.
  Pubblicazione: (2024)
• GLP ‐1 receptor agonists and cardiovascular events in metabolically healthy or unhealthy obesity
  di: Tommaso Bucci, et al.
  Pubblicazione: (2025)
• Practical strategies to manage obesity in type 2 diabetes
  di: Helena W. Rodbard, et al.
  Pubblicazione: (2024)
• Beyond diabetes and obesity: GLP ‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and neuroinflammation
  di: Renata Spezani, et al.
  Pubblicazione: (2025)
• Cardiovascular and kidney outcomes of GLP ‐1 receptor agonists in adults with obesity: A target trial emulation study
  di: Huilin Tang, et al.
  Pubblicazione: (2025)